Ilyang Pharmaceutical Co.,Ltd

₩6,670As of Sun 8 Nov 2026, 12:00 UTC
KRX:007570Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (15.69%)
Div yield 2.32%
ROE 7.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.39
PE TTM 7.048
TSR TTM —
Mkt cap ₩119.6B
ROIC (3.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩7,372
10.53%
(65.63%)
Hold 0|11|4|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
139.36
154.38
154.02
160.43
12.28%
24.50%
18.48%
10.23%
Revenue₩B
6.449
6.822
7.231
7.028
1.15%
3.94%
7.90%
7.82%
Peers (US$88.15M)
Cap (US$)
PE
92.70M
13.42x
79.31M
—
88.22M
17.20x
Capital
TTM
5Y
10Y
Leveragex
4.615
3.547
2.509
EBIT/Intx
0.546
0.186
0.187
Own earn%
17.90
4.91
4.66
Sh yield%
32.85
41.99
46.18
Owners
Insiders/Inst%
6.18
51.21
Short interest%
0.59
SBC / revenue%
0.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
12–19
$1 testx
0.0
Incr. ROIC%
5